Telehealth

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

A health-tech firm with a mission for free care and a $1.3B valuation eyes a Nasdaq listing, but its revenue-free history raises critical questions.

Insulet launches its tubeless Omnipod 5 insulin pump and new Discover data platform in the Middle East, offering a new lifeline for a region in need.

A new partnership will integrate data from millions in India and the UAE, aiming to fix research bias and build more equitable AI-driven medicine.

A new data intelligence platform with 90M data points aims to transform how hospitals manage stroke programs, promising new clarity and a competitive edge.

Wolters Kluwer's UpToDate again tops KLAS rankings, highlighting a major trend: integrating expert-backed patient education directly into clinical care.

A landmark acquisition aims to fix trial diversity and access by moving research from far-off labs into your neighborhood doctor's office. Here's why it matters.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

Organon expands its Women's Health Accelerator to META, aiming to close health gaps and unlock a potential £1 trillion economic boost through digital innovation.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

A new feature sends a compliant text moments before an AI call, promising to boost connection rates, enhance revenue, and rebuild trust in sales outreach.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

As CFO Scott Ullem preps for a key presentation, Edwards balances record innovation and strong financials against new regulatory hurdles. What's at stake?

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

Following the departure of its R&D head, Immunocore streamlines leadership, betting on internal experts to drive its next wave of innovative therapies.